XML 19 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Private Placement
Common Stock
Common Stock
Private Placement
Treasury Stock
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2019 $ 87,153   $ 23     $ 237,931     $ (150,801)
Beginning balance, Shares at Dec. 31, 2019     22,654,444            
Issuance of common stock under employee benefit plans 286         286      
Issuance of common stock under employee benefit plans, Shares     36,472            
Vesting of restricted stock awards 4         4      
Vesting of restricted stock awards, Shares     102,221            
Repurchase of unvested restricted stock awards         8,787        
Retirement of treasury shares         (8,787)        
Stock-based compensation expense 1,693         1,693      
Unrealized loss on marketable securities (53)             $ (53)  
Net loss (18,452)               (18,452)
Ending balance at Mar. 31, 2020 70,631   $ 23     239,914   (53) (169,253)
Ending balance, Shares at Mar. 31, 2020     22,793,137            
Beginning balance at Dec. 31, 2019 87,153   $ 23     237,931     (150,801)
Beginning balance, Shares at Dec. 31, 2019     22,654,444            
Unrealized loss on marketable securities 81                
Net loss (34,137)                
Ending balance at Jun. 30, 2020 122,131   $ 27     306,961   81 (184,938)
Ending balance, Shares at Jun. 30, 2020     27,223,796            
Beginning balance at Mar. 31, 2020 70,631   $ 23     239,914   (53) (169,253)
Beginning balance, Shares at Mar. 31, 2020     22,793,137            
Issuance of common stock   $ 64,317   $ 4     $ 64,313    
Issuance of common stock, Shares       4,029,411          
Issuance of common stock under employee benefit plans 525         525      
Issuance of common stock under employee benefit plans, Shares     70,904            
Vesting of restricted stock awards 5         5      
Vesting of restricted stock awards, Shares     330,344            
Repurchase of unvested restricted stock awards         10,642        
Retirement of treasury shares         (10,642)        
Stock-based compensation expense 2,204         2,204      
Unrealized loss on marketable securities 134             134  
Net loss (15,685)               (15,685)
Ending balance at Jun. 30, 2020 122,131   $ 27     306,961   81 (184,938)
Ending balance, Shares at Jun. 30, 2020     27,223,796            
Beginning balance at Dec. 31, 2020 95,181   $ 28     316,775   (2) (221,620)
Beginning balance, Shares at Dec. 31, 2020     27,941,566            
Issuance of common stock 47,407   $ 5     47,402      
Issuance of common stock, Shares     4,600,000            
Issuance of common stock under employee benefit plans 93         93      
Issuance of common stock under employee benefit plans, Shares     11,888            
Vesting of restricted stock awards 1         1      
Vesting of restricted stock awards, Shares     40,982            
Repurchase of unvested restricted stock awards         1,836        
Retirement of treasury shares         (1,836)        
Stock-based compensation expense 2,073         2,073      
Unrealized loss on marketable securities (2)             (2)  
Net loss (16,999)               (16,999)
Ending balance at Mar. 31, 2021 127,754   $ 33     366,344   (4) (238,619)
Ending balance, Shares at Mar. 31, 2021     32,594,436            
Beginning balance at Dec. 31, 2020 95,181   $ 28     316,775   (2) (221,620)
Beginning balance, Shares at Dec. 31, 2020     27,941,566            
Unrealized loss on marketable securities (7)                
Net loss (36,647)                
Ending balance at Jun. 30, 2021 110,890   $ 33     369,133   (9) (258,267)
Ending balance, Shares at Jun. 30, 2021     32,659,740   21        
Beginning balance at Mar. 31, 2021 127,754   $ 33     366,344   (4) (238,619)
Beginning balance, Shares at Mar. 31, 2021     32,594,436            
Issuance of common stock under employee benefit plans 242         242      
Issuance of common stock under employee benefit plans, Shares     30,008            
Vesting of restricted stock awards 1         1      
Vesting of restricted stock awards, Shares     35,296            
Repurchase of unvested restricted stock awards         2,435        
Retirement of treasury shares         (2,414)        
Stock-based compensation expense 2,546         2,546      
Unrealized loss on marketable securities (5)             (5)  
Net loss (19,648)               (19,648)
Ending balance at Jun. 30, 2021 $ 110,890   $ 33     $ 369,133   $ (9) $ (258,267)
Ending balance, Shares at Jun. 30, 2021     32,659,740   21